Gemina Laboratories Ltd. engages in the development of a platform for detecting pathogens that affect humans and animals. It focuses on the development of novel surface functionalization chemistries for the detection of pathogens and biomarkers. The company was founded by John Davies on October 10, 2017 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company